EMERYVILLE, Calif., March 7, 2014 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing non-antibiotic, topical anti-microbial products, today reported fourth quarter 2013 and fiscal year 2013 financial results and provided a clinical and business update.
Help employers find you! Check out all the jobs and post your resume.
